Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 10/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 9/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.53 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17857883 | 0.95 | NMUR2 (0.59) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29973256 | 0.95 | NMUR2 (0.58) | NMUR2NMUR1OPRM1OPRD1EPHA2 | |
| Acetic Acid SCHEMBL30979611 | 0.94 | NMUR2 (0.58) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL30979614 | 0.93 | OPRM1 (0.58) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29416537 | 0.93 | OPRM1 (0.58) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29484754 | 0.92 | OPRM1 (0.58) | NMUR2NMUR1OPRM1OPRD1EPHA2 | |
| SCHEMBL30695569 | 0.92 | OPRM1 (0.56) | NMUR2NMUR1OPRM1OPRD1EPHA2 | |
| SCHEMBL30728124 | 0.92 | NMUR2 (0.57) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL30233902 | 0.91 | OPRM1 (0.62) | NMUR2NMUR1OPRM1OPRD1EPHA2 | |
| SCHEMBL11033085 | 0.90 | NMUR2 (0.57) | NMUR2NMUR1OPRM1OPRD1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186339-A1 | COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | SCHWARZ JOSEPH (CA) | 2025-06-12 | — | — | US | disclosed |
| US-12246087-B2 | Composition for intraoral delivery of biologically active peptides and proteins | PHARCON INC (CA) | 2025-03-11 | — | — | US | disclosed |